187
2305
TESTICULAR
James Department The
IN THE BABOON PAP10 --
STEROIDOGENESIS P.
Preslock
of
Reproductive
University
of
Emil
and
Texas
Steinberger
Medicine Medical
ANUBIS
and
School
Biology
at
Houston
and Program The
in
University
Received
of
Reproductive Texas
Biology
Graduate
School
Houston,
Texas
and
Endocrinology
of
Biomedical
Sciences
)+-14-78 ABSTRACT
converts pregnenolone We recently reported that the baboon testis studies were to testosterone through the delta-4 pathway. The present de1 tato determine the metabolism of intermediates of the delta-4 and Fragments (50 mg) were incubated for 3 5 pathway by the baboon testis. pregnenohr with 10 nCi of the following tritium-labelled substrates: lone, progesterone, 17-hydroxypregnenolone, 17-hydroxyprogesterone, Pregnenolone dehydroepiandrosterone, androstenedione, or testosterone. the delta-4 pathway, was converted to testosterone primarily through progesterone, 17-hydroxyprogesterone and 20awith accumulation of dihydroprogesterone as predominant intermediates. Similar results were obtained in progesterone incubations. 17-Hydroxyprogesterone was not efficiently metabolized by the fragments, while 17-hydroxypregconverted nenolone and dehydroepiandrosterone were efficiently into testosterone and androstenedione. Androstenedione was metabolized primarily to testosterone, while testosterone was not a suitable substrate. Sane 5u-androstanediol was identified in each incubate. These results suggest that al though testosterone is formed from the delta-5 intermediates pregnenolone through the de1 ta-4 pathway, the baboon are more suitable substrates for testosterone synthesis in testis.
The vert
of
the
pregnenolone
pathway. lone
testis
to
This
pathway
subhuman
to
testosterone of
conversion
progesterone,
with
17_hydroxyprogesterone,
to
VoZwne
32,
Number 2
primate
a
S
has
been
primarily involves
further
androstenedione,
TDEOXDI
demonstrated through
the
metabolism
metabolism and
of then
to
of
con-
de1 ta-4 pregneno-
progesterone to
to
testosterone.
September,
2978
This
pathway
has
mosets
Saguinus
baboon
Papio
Macaca
mulatta
In
our
conversion ments.
the
studies
anubis
of
studies
was
(41,
pregnenolone
However,
we did enzymes
delta-4
or
the
therefore
steroidogenic
establish
the in
and
and
as
predominant
Callithrix
earlier
in
jacchus
reported
in
the
(3),
the
mar-
in
Rhesus
the
monkey
(5).
earlier
were
reported
(1,2)
(4),
testicular
synthesis
recently
Oedipus
steroidogenic of
been
to not
by
testosterone
determine
investigating
delta-5
pathways
undertaken enzymes
delta-4
this
we demonstrated
pathway
subhuman
primate
to in as
a
by
predominant
baboon
the
specificity
the
metabolism
by
baboon
Papio
testicular of of
testes.
investigate anubis,
f ragtesticular
intermediates The
the
predominant
de 1 ta-4
following
specificity and
for
to
of further
testosterone
specie.
MATERIALS AND METHODS Testicular
Tissues:
Testes were removed from mature baboons (Papio anubis) and placed were weighed, into ice-cold tris-sucrose buffer, pH 7.4. The---- testes and cut into approximately equal 50 mg fragments. The decapsulated, fragments were teased apart and placed into flasks for incubation studies. Materials: silica-gel (Silicar (nanograde 1 and Solvents Louis; purchased from Mallinckrodt Chemical Works, St. Wil ton, steroid carriers were ob ained from Steraloi f tracers cPaC) were Radioactive substrates ( Ii) and Amersham Searle, Inc., Arlington Heights, Ill. Cofactors incubations were obtained from Sigma Chemical Co., St. purchased 1) for chranatographic separations was (No. Steroids were checked for purity Company. Paper chromatography, while paper and silica gel were washed prior to use in these studies.
were TLC- 7Gf ) nonradioactive New Hampshire. purchased from utilized for Louis. Paper from Whatmann thin-layer by with
methanol
S
-lFDEIEOXDrn
Incubations: Testicular fragments were placed into incubation flasks containing Krebs-Ringer bicarbonate buffer, pH 7.4, fortified with NADH, and an NADPH generating system which contained NADP, nicotinamide, glucose6-phosphate, pyruvate, glucose-6-phosphate dehydrogenase, and lactic dehydrogenase. The fragments were incubated for 3 hr with 10 uCi of the following tritium-labelled substrates: pregnenolone, li'-hydroxypregnenolone, dehydroepiandrosterone, progesterone, 17-hydroxyprogesterone, androstenedione, and testosterone. Each substrate was incubated in triplicate for a total of 21 separate determinations. Incubations were performed in a Dubnoff metabolic shaking incubator at 37'C under an atmosphere of 95% 0 15% CO . Upon completion of the incubations the reactions were teriinated sith 0.5 ml 1N HCl, and the incubates were immediately frozen. Extractions: The incubates were thawed and the testicular fragments were homogenized in Krebs-Ringer bicarbonate buffer pli 7.4. The homogenized fragments were pooled with their Radiolabelled tracers (14C) and ,lab~~E~~ct~,",rie~~u~~~onadd~~di~~ each pool, and the pools were extracted ten times with cold diethyl ether:chloroform, 4:l. The solvents were evaporated with nitrogen, and the residues were concentrated. M'ethanol (5 ml) was added to each tube and aliquots were removed for estimates of recoveries. The remaining solvent was evaporated under nitrogen, and the residues were placed onto paper strips for chromatographic separations. Chromatographic procedures: The residues were placed onto Whatmann No. 1 paper strips (2.5 x 50 cm) which were impregnated with formamide. The strips were chromatographed in hexane, with a second chromatographic separation in a hexane:benzene mobile phase. Upon completion of the chrcmatographic separations, the paper strips were dried in a warm air oven. The radioactive peaks were located with a Packard Model 385 Recording Ratemeter. The peaks were eluted from the paper strips with 80 ml of methanol, and the metabolites were isolated by thin-layer chranatography in selected solvent systems. The systems utilized in these studies were benzene:ethyl acetate (80:20, 60:40), benzene:methanol (98:2, 95:5), and chloroform:acetone (90:10, 80:20). Testosterone, 2Oa-dihydroprogesterone, 5a-androstanediol and dehydroepiandrosterone were acetylated, and were separated by thin-layer chromatography. Aliquots for recovery determinations were obtained prior to each thin-layer separation and prior to crystallization of each metabolite. Crystallization procedures: Following isolation and tentative identity by thin-layer chromatography, final identity of each metabolite was es5abi&shed by crystallization to constant specific activities and HI C ratios through
three successive solvent combinations (acetone:hexane; acetone:cyclohexane; acetone: hexane). Conversion qf substrates to metabolites was calculated by determining the total H-DPH for 3each metabolite from crystallization data, correcting the t tal H-DPM for procedura 1 q and dividing the corrected total losses,3 H-DPM for each metabolite by the H-DPM of thq total incubate. Conversions were expressed as a percentage of the 5a-Androstanediol H-DPM of the total incubate. and 2Oa-dihydroprogesterone, although not crystallized, were identified by acetylation and comparison of relative mobilites in four separate thin-layer chranatographic Percent sys terns. conversion of each substrate into these metabolites was estimated from recovery the data. RESULTS Baboon to
testosterone
gesterone, the of
testicular
primarily
metabolites
respective
delta-5
the
was
incubates,
was
1.1%
while
A as
( 0.8%)
were
the
was
non-metabolized
pregnenolone
pathway
(Fig.
30,5%,
minor
in
the
radioactivity 1.5%.
identified
as
pregnenolone
Pro-
in
Sane
and
of
was
24.2%
through
the
(0.9%)
and
incubates. the
occurred
radioactivity,
the
14.8%
Tes-
pregnenolone
5a-reduction
2.4%
substrate
were
19.32,
conversion
identified
was
1).
20a-dihydroprogesterone
17-hydroxypregnenolone
total
androstenedione
5a-androstanediol
delta-4
representing
apparent
of
radiolabelled
and
radioactivities.
pathway
tosterone
while
through
identified,
dehydroepiandrosterone
as
converted
17-hydroxyprogesterone,
major the
fragments
of
the
incubate
radioactivity. Similar since
results
progesterone
were
while
was
(36.3%) 1.1%
of
the
5a-androstanediol
demonstrates incubations.
crystallization
in
progesterone
incubates
17-hydroxyprogesterone
(29.5%),
dihydroprogesterone tosterone
obtained
were
the
major and
radioactivity
was
4.3% data
of
the for
total
(23.7%)
steroids
11,
and
2Oo-
identified.
androstenedione radioactivity.
pregnenolone
(Fig.
and
Teswas
1.9%,
Table progesterone
1
191
Figure
Percent (X) conversion of ptegnenolone and progesterone to metabolites by baboon testicular fragments. The following abbreviations are used in the figures: PRR, pregnenolone; PRO, progesterone ; 17-PRO, S7-hydroxy20a-dihydroprogesterone; progesterone; 20a-PRO, 17-PRR, 17-hydroxypregnenolone; DEA , dehydroepiandrosterone; AND, androstenedione; TRS, testosterone; 5a, 5a-androstanediol.
1.
A substantial remained
(5.7%)
of
for
of
testosterone
Incubations conversion
of
with of
this
the
with
synthesis
occurred
pathway by
of
Table
2).
androstene-
the delta-4
more
suitable
testicular
resulted
testosterone
(86.5%)
in the incubates.
were
baboon
2;
C?.OX) f
intermediates
17-hydroxypregnenolone into
(Fig.
to testosterone (3.8%)
delts-5
substrate
substrate
the 3 hr incubation
substrate
to incubations
intermediates
strates
this
17-hydroxyprogesterone
and 5a-androstanediol
In contrast way,
of
at the termination
Some conversion dione
portion
in and
pathsub-
fragments. a
substantial
androstenedione,
a
TES AND 5a
3,360 2,670 3,540 118 210 474
---149 il0 160 5 10 22
Z 6 8 13
164 99 128 86
3H DPM/III~~'~
48 3 4 7
1.8 1.3 1.6 2.1
1.6 1.1
3 9
91 97
106 90
1.5 1.1
1.6 1.1
3R/'4C
___II
14C DPM/mge'f
2,970 2,190 3,200 103 195 435
3,270 1,970 2,560 1,730 100 84 118 169 264
3H DPM (T)g
^ 88 82 90 87 93 92
91 92 90 93 92 89 94 91 92
% Pur&
% Purity = 3R DPH (T)/3R DPM (I),
17-PRO, 17-hydroxyproThe following abbreviations are used in the tables: PRO, progesterone; gesterone; 2&r-PRO, ZOC-dihydroprogesteron~; PRE, pregnenolone; If-PRE, 17-hydroxypre%~en~lone; DEA, dehydroepiand~oster~ne; TES, testosterone; AND, androstened~one~ 5a, Sa-androstanediol. Approximately 20 mg of crystalline steroid was added to each sample prior to crystallization. ~on~~ta~oliz~d subgtrate. Initial H-DPM (Xl.0 )3before crystallization. Data as mean DPM (XI0 ) of three successive crystallizations of duplicate samples. Solvent systems for crystallizations were: 1. Acetone/Hexane; II. Acetone/Cyclohexane; III. Acetone/ Nexane3 Total H DPM (X~03) following crystallization,
2oa-PRO
PRO 17-PRO
FFo~esteroneYZFstrate
.-~_I___~
Crystallization $ata for metabolism of pregnenolor~-7-~H (10 pCi> and progesterone-7- H (10 uCi) by baboon testicular fragments (Papio anubis) at 3 hr of incubation. ---
2:
3H DFM (T)d Metabolite s,b Prennenolane substrate PRO_ 3,580 17-PRO 2,140 2,840 20a-PRO PREC 1,610 17-PRE 108 DE#i 95 126 TES AND 186 286 5iY
~-~-
TABLE
S these
representing
metabolites
radioactivities
(Fig.
17-hydroxyprogesterone identified
into
substrate
remained
Figure
(0.4X),
2.
metabolites
of
the
respective
Dehydroepiandrosterone
(0.3X),
(3.0%)
17-Hydroxypregnenolone
was
by the baboon of
testis
as only
0.3%
were readily of
this
the incubations.
(X) conversion of 17-hydroxyprogesterone and 17Percent tes titular hydroxypregnenolone to metabolites by baboon Figure 1 lists metabolite abbreviations. fragments.
terone
and androstenedione
of
total
androsterone
62.1%
5a-androstanediol
and
upon termination
Dehydroepiandrosterone
the
and
2).
metabolites.
as minor
converted
28.2%
Table
2,
193
?EBEOXDb
was also
a suitable
substrate
these
metabolites
were
27.9%
( 1.3%)
and
as
radioactivity. substrate
5a-Androstanediol. (2.5%)
were also
identified
for and
testos59.8%
dehydroepi-
in the incubat.es.
a,b
8
h
substrate 42 32 3,570 7,870 355 42
substrate 8,960 209 785 301
311 DPM (Xld
2 2 167 364 16 2
407 11 35 14
3 H DPPf/mge,f
1 92 302 2
1.2
415 7 29
3H/ 14C
1.4 1.8 1.2
.9 1.6 1.2
14 C DPM/mge,f
37 31 3,340 7,280 321 37
8,130 230 706 280
3H DPM (Tjg
Crystallization data for metabolism of 17-hydroxyprogesterone-73W (10 nCi1 and 17-hydroxypregnenolone (10 uCi) by baboon testicular fragments (Papio anubis) at 3 hr of incubation --
Table 1 lists metabolite abbreviations. Approximately 20 mg of crystalline steroid was added to each sample prior to crystallization. Non-meta olized subgtrate. $ Initial H DPM (X10 l3before crystallization. Data as mean DPM (Xl0 ) of three successive crystallizations of duplicate samples. Acetone/Hex~~; II. Acetone~Cyclohe~~ne; System for crystallizations *i-e: I. Solvent Acetong/Nexane. crystallization. Total W D9 (X1031 fojlowing X Purity = N DPM CT)/ H DPM (I).
-l7-Hydroxypreg~~~lone 17-PRl?F DEA TRS AND 5a 17-PRO
5a
17-Hydroxyprogesterone 17-PRO’ Tl?s AND
Metabolite
TABLe 2:
87 94 94 93 90 89
91 91 90 93
III.
Purityh
s A substantial strate
portion
was converted
of
into
portion
of
the substrate
period.
5a-Androstanediol
195
lCBEOXDIll
the
radiolabelled
testosterone (5.8%)
(86.9X),
remaining
was 2.4%
androstenedione
of
at
with
anly
the end of
the
total
the
suba
small
incubation
radioactivity
from
androstenedione. Testosterone fragments
since
incubation
g7.iX
period.
converted (1.4%).
was not a suitable
into Figure
of
testosterone
However,
3.
a
androstenedione 3 and Table
andros terone ) androstenedione
Figure
substrate
3
for
baboon
testicular
remained
at
the
portion
of
testosterone
small (4.9.%),
and
demonstrate and testosterone
the
into data
end
of
the was
So-androstanediol for
dehydroepi-
incubations.
Percent (%I conversion of dehydroepiandrosterone, stenedione and testosterone to metabolites by testicular fragments. Figure 1 lists metabolite viatians.
androbaboon abbre-
339 36 15
607 34 17
Androstenedione substrate TBS ANDC 8,850 825 5ci 319
Testosterone substrate TESC 13,800 AND 741 5u 380 1.6 1.1
1.6 1.0
361 31
211 34
8
1.3 ___--_I_--
73 234
--
3H/"4C
1.6 1.0
-
---p14 C DpM/mg e,f
12,100 680 343
7,980 724 302
2,440 4,880 114 211 _p--
__--
3H DPM (T)'
W-P
III.
88 92 90
90 88 95
94 92 91 89
% Purityh
Table 1 lists metabolite abbreviations. Approximately 20 mg of crystalline steroid was added to each sample prior to crystallization. Non-meta olized subgtrate. 9 Initial H-DPM (X10 j3before crystallization. Data as mean DPM (X10 ) of three successive crystallizations of duplicate samples. II. Acetone/Cyclohexane; Solvent systems for crystallizations were: I. Acetone/Hexane; Acetone/Hexane. Total 3H DPM (X103) following crystallization. % Purity = 3H DPM (T)/~H DPM (I).
122 244 6 11
3H DPM (IId
3 H DPM/mg e,f
D~bydroepiandrosterone substrate TBS 2,610 AND 5,300 5o 126 DEAC 237
Metabolite a,b
TABLE 3: Crystallipation $ata for metabolism of dehydroe~ia*d~osterone-7-3H (10~ Ci), androstenedione-7- H (10 PCi) and testosterone-7- H (10~ Ci) by baboon testicular fragments (Papio anubis) at 3 hr of incubation. --
_DISCUSSION results
The
the baboon
of
Papio
marily
through
bolism
of
the delta-4
are
pathway.
to
similar
Saguinus
to recent
Oedipus -.
Th is
testis
of
testosterone
pri-
involves
meta-
17_hydroxyprogesterone,
with
progesterone
identified findings
(1,2)
to
the
conversion
progesterone,
metabolites
that
pregnenolone
as intermediates,
the major
demonstrate
convert 8
pregnenolone
gesterone
moset
experiments
anubis
androstenedione
results
these
in
and the
17-hydroxypro-
incubates.
which we reported
in which
the
and
delta-4
The se
in
the
mar-
pathway
was
pre-
dominant. is
It
perhaps
significant
that
marily
through
terone
and 17-hydro~progest.erone
testosterone baboon
the delta-4
pathway,
testicular
fragments
the total
radioactivity
synthesis
within
within
delta-4
in fact
the delta-4
intermediates.
species,
the
the pathway for
a consequence pregnenolone genase
of
of
baboon
is metabolized
and isomerase
of
other
of
primate
pregnenolone
specific
primarily is
testosterone
by
and
3S-hydroxysteroid into
of
suggest
testosterone the
delta-5 than
are
non-primate
to testosterone
testicular
converted
tes-
portion
results
the intermediates
of
, pregnenolone
These
for
and
when
pathway,
substantial
into
to
17-hydroxypregnenolone
the delta-5 a
proges-
However,
predominant
converted
conversion
the activities
for
pri-
converted
testis.
with of
is
testis,
more readily
efficiently
incubates.
the
pathway
the baboon
pathway are
In the testis
accounted
occurred
intermediates
by the baboon
intermediates
and androstenedione
the
not
were
were incubated
tosterone
although
metabolism
the delta-4
or to androstenedione
and dehydroepiandrosterone,
that
although
enzymes.
is If
dehydro-
progesterone
and
a predominant is
metabolized
is
converted
delta-4 primarily into
delta-5
pathway
testis,
the
permit
the
(8,9).
of
pregnenolone
pathway.
pathway
are
and
more
to
a
baboon
lwer
with
conversion
of
by
baboon
predominant the
of
testosterone pathway
pregnenolone
may
3S-hydroxy-
consequent
intermediates
delta-4
the
17-hydroxylase
a
to
predominant in
progesterone
converted the
that
pregnenolone
the
testis,
pregnenolone
a consequent
suggest
to
although
efficiently
the
of
isomerase ,
Therefore,
pregnenolone
17-hydroxylase,
results
metabolism
if
However,
with
present activity
delta-4
due
The lower
by
(6,7).
pregnenolone
apparent
dehydrogenase
nant
by
results
17-hydroxypregnenolone
steroid
stenedione
pathway
de1 ta-5
and
may to
be
andropredomi-
17-hydroxypreg-
nenolone. We have
recently
Oedipus
where
mediates
of
the the
testosterone
it
subhuman
pathway
However,
through
appears
the
preferred
earlier
was
was
the
delta-5
there
by which
more
converted was
into
apparently
the
in
no
incubates.
As
differences
specie is
inter-
17-hydroxypregnenolone
since
substantial
Saguinus the
although
there
identified
pregnenolone
marmoset
efficiently
marmoset,
not
the
predominant
pathway
are
in
converted
within
testosterone
into
tissue.
results
from
substrate
efficiently
lone
in
results
were
were
that
primates
testicular The
was
delta-5
similar
pathway
dehydroepiandrosterone
such,
by
delta-4
(10).
conversion and
reported
these for
converted
poorly
converted
postulated
that
studies
baboon into
suggests
testicular
that
progesterone
into progesterone
17-hydroxypregnenolone. is
the
preferred
the
Progesterone
17-hydroxylase.
17_hydroxyprogesterone,
is
while
pregnenoTamaoki
substrate
(7) for
S 17-hydroxylase. reported
However,
that
TPEOXD-
Fevold
17-hydroxylase
(8,9)
and,
more
preferentially
recently,
converts
Kremers
(11) into
pregnenolone
17-hydroxypregnenolone. It
is
interesting
that
there
2&-dihydroprogesterone progesterone marmoset major
substrates. Callithrix
incubated
when
with reported
(12,131 gesterone
in
tosterone Brownie
the
predominant subhuman In
the
pathway.
delta-4
conversion
studies
metabolites
in
enzyme the
may
testis
Saguinus
to
of
progesterone Steinberger
a
the was
a
were nt
metabolite
fragments
which the
the
of from
biosynthesis
Rhesus
formation Sharma
monkey. of
aJ. pro-
normal,
of
al.
to
tes-
Hoschoian
testosterone
et --
pregnenolone
the
of
Papio
baboons,
incubates
increased
(1,2).
were
the by
step as
is
and occurs
reported
(5)
testosterone
in
a this
of
low
interesting
these and
we recently
the
testosterone reported
and
metabolites
within
2Oo-hydroxysteroid
conversion
C17-C201yase for
that
17-hydroxyprogesterone
17-hydroxylase
However,
rate-limiting anubis,
it
accumulation
androstenedione
be
Oedipus
in
However,
The
activities.
progesterone
humans, as
in
the
with
the
suggests
dehydrogenase
in
specie.
present
incubates
or
testicular
is
that
20a-dihydroprogesterone. the
In
primate
delta-5
primate
demonstrated
and
subjects.
investigated
reported
pregnenolone
pregnenolone
human
subhuman
been
(14)
through
of
of
2Oa-dihydroprogesterone
fragments.
Klinefelters
other
has
that
accumulation
both
previously
20a-dihydroprogesterone
and
only
(3)
significant with
have
radiolabelled
incubates
azoospermic, The
We
testicular
a
incubates
jacchus
metabolite
major
in
was
of
17-hydroxy-
suggests
that
synthesis in
the
this within
marmoset
Although we utilized only a three
hr
incubation
in
the
present
studies, which precluded the detection of an early conversion of nenolone to testosterone through the delta-5 pathway,
it
that any major conversion occurred through this pathway. 17-hydroxyprogesterone
and
20a-dihydroprogesterone
a
minor
Progesterone,
conversion and
epiandrosterone were identified in
in
incubates,
but
for
within
through the delta-5 pathway since 17-hydroxypregnenolone the
unlikely
accounted
substantial portion of the radioactivity from pregnenolone incubates. However, it is apparent that
is
preg-
a the
occurred dehydrovery
low
levels.
ACKNOWLEDGMENTS The skilled technical assistance of Mr. Charles E. Sutherland, Jr., is gratefully acknowledged. This work was supported by NICHD Grant P50-HD-08338. REFERENCES
1. Preslock, J.P., and E. Steinberger, STEROIDS 28, 775 (1976). 101 31 2. Preslock, J.P., and E. Steinberger, GEN COMP. ENDOCRINOL. -' (1977). 3. Preslock, J.P., and E. Steinberger, BIOL. REPROD. 17, 289 (1977). 547 33 4. Preslock, J.P., and E. Steinberger, GEN. COMP. EmINOL. _' (1977). 499 5. Sharma, D.C., S.G. Joshi, and R.I. Dorfman, ENDOCRINOLOGY 80, (1967). 6. Tamaoki, B.I., Il. Inano, and H. Nakano, In: The Gonads: McKerns, NHPC, 547 (1963). 7. Tamaoki, B.I., J. STEROID BIOCHEM. 4, 89 (1973). 8. Fevold, A.R., SCIENCE. 156 1753 (1767). 211 BIOCHEM. BIOPHYS. ACTA. -’313 9. Fevold, A.R., and H.B. &ond, (1973). 163 10. Preslock, J.P., and E. Steinberger, J. STEROID BIOCHEM. 2, (1978). 11. Kremers, P., J. STEROID BIOCHEM. 7, 571 (1976). 12. Steinberger, E., M. Ficher, and K.D. Smith, In: The Human Testis: Rosenberg and Paulsen (1970). 13. Steinberger, E., K.D. Smith, R.K. Tcholakian, M. Chowdhury, A. Steinberger, M. Ficher, and C.A. Paulsen, In: Male Sterility and Fertility. Mancini and Martini (1973). 14. Hoschoian, J.C., and A.C. Brownie, STEROIDS -10, 49 (1967).
S The following
trivial
201
TP&OXDO names were utilized
in the text:
Pregnenolone: 3g-hydroxy-5-pregnen-20-one Progesterone: 4-pregnene-3, 20-dione 17-Hydroxypregnenolone: 38, 17-dihydroxy-5-pregnen-20-one 17-Hydroxyprogesterone: 17-hydroxy-4-pregnene-3, 20-dione 20a-Dihydroprogesterone: 20a-hydroxy-4-pregnen-3-one Dehydroepiandrosterone: 3B-hydroxy-5-androsten-17-one Androstenedione: 4-androstene-3, 17-dione Testosterone: 17B-hydroxy-4-androsten-3-one 5a-androstanediol: 5a-androstane-3a, 17g-diol